Leidos Awarded Contract By Naval Medical Logistics Command
- Company to Provide Research and Development Services for the Behavioral Sciences and Epidemiology Department
Leidos (NYSE: LDOS), a national security, health and engineering solutions company, was awarded a prime contract, Behavioral Epidemiology Assessment Research (BEAR), by the Naval Medical Logistics Command to provide research services for multiple behavioral health and epidemiology projects that support the Naval Health Research Center's (NHRC) Behavioral Sciences and Epidemiology Department. The single-award cost-plus fixed-fee (CPFF) contract has a one-year base period of performance, four one-year options and a total contract value of approximately $7.3 million, if all options are exercised. Work will be performed primarily in San Diego, Calif.
The NHRC's Behavioral Sciences and Epidemiology Department is dedicated to the study of behavioral trends that impact warfighter readiness. The department examines operationally relevant issues affecting personnel such as combat and operational stress, posttraumatic stress, misconduct, substance use, suicide and career-span health and wellness issues. Under this contract, Leidos will conduct behavioral and epidemiological investigations that address these and other deployment-related health issues. Specific examples of these studies may include determining factors related to the onset of mental disorders in military personnel; mental health surveillance of combat-deployed personnel; assessing the effects of adverse lifestyle behaviors on health, performance, and healthcare costs; and investigating the effects of acute stress on military personnel.
Unmanned Cargo Aircraft (UCA) Systems Market Report 2016-2026
"Finding ways to improve the health and wellness of our military personnel and their families is important to the Nation, which means it's important to Leidos," said Steve Comber, President of Leidos Health. "We are pleased to continue our support of NHRC to help ensure our military is prepared to perform every mission."
Source : Leidos - view original press release
Feb 28 - Mar 2, 2017 - London, United Kingdom